It was reported that the procedure was to treat a mildly tortuous, moderately calcified superficial artery that had restenosed.A command es wire was crossed and a 5x100mm armada 35 balloon was advanced to the lesion to pre-dilatation.Then a 5.5x100mm supera stent was advanced to the lesion and deployment was initiated.However, during deployment, it was noted that the stent implant only deployed partially at first.After multiple attempts, the stent deployed completely, however the stent implant was noted as compressed and did not cover the entire target lesion as planned.The delivery system was not removed under fluoroscopy.Another 5.5x80mm supera was used to successfully complete the procedure and cover the entirety of the target lesion.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
|
The device was returned for analysis.The reported difficult or delayed activation was unable to be confirmed due to the condition of the returned device.The reported defective device shortened was unable to be confirmed as the stent was not returned.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.Reportedly, the delivery system was not removed under fluoroscopy.It should be noted that the supera peripheral stent system instructions for use states: under fluoroscopy, remove the device from the guide wire and evaluate the improved luminal quality of the treated area.The deviation of the ifu does not appear to have caused/contributed to the reported difficulties.It is possible that during stent deployment interaction with the mildly tortuous and moderately calcified anatomy and/or other devices resulted in the ratchet being unable to properly engage/fully deploy the stent; thus resulting in reported difficult or delayed activation; however this cannot be confirmed.Additionally, it is possible that the delivery system was slightly pushed distally as the stent was being deployed resulting in the reported defective device shortened/compressed stent; however, this could not be confirmed.The investigation determined a conclusive cause for the reported difficulties cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling of the device.H6, code 2976 removed.
|